At a glance
- Originator Nonindustrial source
- Class Antimalarials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Malaria
Most Recent Events
- 25 Feb 1999 New profile
- 25 Feb 1999 Preclinical development for Malaria in USA (Unknown route)